Pathological investigation of sentinel lymph nodes

European Journal of Nuclear Medicine

Volumn 26, Issue SUPPL., 1999, Pages

  Van Diest, Paul J ^a   Peterse, Hans L ^b   Borgstein, Paul J ^a   Hoekstra, Otto ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Flow cytometry; Frozen section; Immunohistochemistry; Imprint cytology; Polymerase chain reaction; Sentinel lymph node

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CONFERENCE PAPER; FLOW CYTOMETRY; FROZEN SECTION; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOPSY; FEMALE; FLOW CYTOMETRY; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE CARE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0032938341     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050577     Document Type: Conference Paper

References (62)

1. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP. Tanabe KK, Laughlin EH, Alex JC. Minimal access surgery for staging of malignant melanoma. Arch Surg 1997; 130: 654-658.
2. Morton DL. Sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol 1997; 66; 267-269.
3. Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital blue guidance. World J Surg 1997; 21: 788-792.
4. Veen H van der, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994; 81: 1769-1770.
5. Decesare SL, Fiorica JV, Roberts WS, Reintgen D, Arango H, Hoffman MS, Puelo C, Cavanagh D. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel node in vulvar cancer. Gynecol. Oncol. 1997; 66: 425-428.
6. Pettaway CA, Pisters LL, Dinney CP, Jurlabal F, Swanson DA, von Eschenbach AC, Ayala A. Sentinel lymph node dissection for penile cancer: the MD Anderson Cancer Center experience. J Urol 1995; 154: 1999-2003.
7. Lechner P. Probe-guided surgery of colorectal carcinoma. Acta Medica Austriaca 1997; 24: 68-72.
8. Javaheri S, Cruse CW, Stadelman WK, Reinigen DS. Sentinel node excision for the diagnosis of metastatic neuroendocrine carcinoma of the skin: a case report. Ann Plast Surg 1997; 39: 299-302.
9. Lowe FC. Squamous-cell carcinoma of the scrotum. Urol Clin North Am 1992; 19: 397-405.
10. Borgstein PJ, Pijpers R, Comans EFI, Diest PJ van. Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection, J Am Coll Surg 1998; 186: 275-283.
11. Giuliano AE. Sentinel lympadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 1996; 62: 75-76.
12. Giuliano AE, Jones RC, Brennen M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350.
13. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339.
14. Meijer S. Less axillary node dissection necessary owing to sentinel node biopsy in breast cancer patients. Ned Tijdschr Geneeskd 1996; 140: 2239-2243.
15. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, Diest PJ van, Teule GJJ. Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38: 366-368.
16. Uren RF, Howman-Giles RB, Thompson JF, Malouf D. Ramsey-Stewart G, Niesche FW. Renwick SB. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-1780.
17. Veronesi U, Paganelli G, Galimberti V, Viale G. Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
18. Brekel MWM van den, Stel HV, Valk P van der, Waal I van der. Meyer CJLM, Snow GB. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Oto rhino laryngol 1992; 249: 349-353.
19. Bachter D, Balda BR, Vogt H, Bücheis H. Primary therapy of malignant melanomas: sentinel lymphadenectomy. Int J Dermatol 1998; 37: 278-282.
20. Lingam MK, Mackie RM, McKay AJ. Intraoperative identification of sentinel lymph node in patients with malignant melanoma. Br J Cancer 1997; 75: 1505-1508.
21. Veronesi U, Zurrida S, Galimberti V. Consequences of sentinel lymph node in clinical decision making in breast cancer and prospects for future studies. Eur J Surg Oncol 1998; 24: 93-95.
22. Richter T. Nährig J, Komminoth P, Kowolik J, Werner M. Protocol for ultra-rapid immunostaining of frozen sections. J Clin Pathol, in press.
23. Diest PJ van, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, Meijer S. Reliability of intra-operative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology. in press.
24. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271-278.
25. Gentry JF. Pelvic lymph node metastases in prostatic carcinoma. The value of touch imprint cytology. Am J Surg Pathol 1986; 10: 718-727.
26. Hadjiminas DJ, Burke M. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 1994; 81: 1615-1616.
27. Fisher CJ, Boyle S, Burke M, Price AB. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 1993; 80: 457-458.
28. Joensuu H, Klemi PJ, Eerola E. Flow cytometric DNA analysis combined with fine needle aspiration biopsy in the diagnosis of palpable metastases. Analyl Quant Cytol Hixtol 1988; 10: 256-260.
29. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, Coombes RC. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994; 54: 2986-2990.
30. Noguchi S, Tomohiko A, Motomura K, Inaji H, Imaoka S, Koyama H. Detection of breast cancer raicrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994; 74: 1595-1600.
31. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 1996; 148: 649-656.
32. Hoon DSB, Sarantou T, Doi F, Chi DDJ, Kuo C, Conrad AJ, Schmid P, Turner R, Giuliano A. Detection of metastatic brest cancer by β-hcg polymerase chain reaction. Int J Cancer 1996; 69: 369-374.
33. Mori M, Mimori K, Inoue H, Barbard GF, Tsuji K, Nanbara S, Ueo H, Akiyoshi T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995; 55: 3417-3420.
34. Liefers GJ, Cleton-Jansen AM, Velde CJH van de. Hermans J. Krieken JHJM van. Cornelisse CJ. Tollenaar RAEM. Micromelastases and survival in slage II colorectal cancer. N Engl J Med 1998; 339: 223-228.
35. Goydos JS, Ravikumar TS, Germino FJ, Yudd A, Bancila E. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. J Am Coll Surg 1998; 187: 182-190.
36. Velde-Zimmermann van der D, Roijers JF, Bouwens-Rombouts A, Weger RA de, Graaf PW de, Tilanus MGJ. Tweel JG van den. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996; 149: 759-764.
37. Blaheta HJ, Schittek B, Breuninger H, Maczey E, Kroeber S, Sotlar K, Ellwanger U, Thelen MH, Rassner G, Bultmann B, Garbe C. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry. Int J Cancer 1998; 79: 318-323.
38. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 429-435.
39. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85: 991-993.
40. Saphir O, Amromin GD. Obscure axillary lymph-node metastasis in carcinoma of the breast. Cancer 1948; 1: 238-241.
41. Pickren JW. Significance of occult metastases: a study of breast cancer. Cancer 1961; 14: 1266-1271.
42. Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978; 42: 2025-2031.
43. Wilkinson EJ, Hause LL, Hoffman RG, Kuzma JF, Rothwell DJ, Donegan WL, Clowry LJ, Almagro UA, Choi H, Rimm AA. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu 1982; 17: 67-91.
44. Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. BrJ Cancer 1986; 54: 631-636.
45. Berry N, Jones DB, Marshall R, Small wood J, Taylor I. Comparison of the detection of breast carcinoma metastases by routine histological diagnosis and by immunohistochemical staining. Eur Surg Res 1988; 20: 225-232.
46. Friedman S, Bertin F, Mouriesse H, Benchabat H, Genin J. Importance of tumor cells in axillary node sinus margins ("clandestine" metastases) discovered by serial sectioning in operable breast cancer. Acta Oncol 1988; 27: 483-487.
47. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary node micrometastases from breast cancers. Lancet 1990; 335: 1565-1568.
48. Bettelheim R, Price KN. Gelber RD. Davis BW, Castiglione M. Goldhirsch A, et al. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990; 335: 1565-1568.
49. Nasser IA, Lee AKC, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993; 24: 950-957.
50. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC. Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996; 73: 88-95.
51. Jannink I, Fan M, Nagy S, Rayudu G, Dowlatshahi K. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann Surg Oncol 1998; 5: 310-314.
52. Wells CA, Heryet A. Brochier J, Gatter KC, Mason DY. The iminunohistocheniical detection of axillary micrometastases in breast cancer. Br J Cancer 1984; 50: 193-197.
53. Trojani M. Mascarel I de, Coindre JM, Bonichon F. Micrometastases to axillary lymph nodes from invasive lobular carcinoma of the breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987; 56: 838-839.
54. Noel P, Tabone E, Michot JP, Groleas M, Hesch M, Rifki AM. Detection of micrometastases in regional lymph nodes of human breast cancer using keratin monoclonal antibodies KLI in a prospective series of 120 patients T2 N-. Ann Pathol 1989;9:265-270.
55. Raymond WA, Leong ASY. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer. Pathology 1989; 21: 11-15.
56. Sedmak DD, Meineke TA, Knechtges DS. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins. Arch Pathol Lab Med 1989; 113: 786-789.
57. Chen ZL, Wen DR, Coulsen WF, Giuliano AE, Cochran AJ. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologie examination and conventional histology. Din Markers 1991; 9: 239-248.
58. Galea MH, Athanassiou E, Bell J, Dilks B, Robertson JFR, Elston CW, Blamey RW, Ellis IO. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM5.2 and NCRC-11. J Pathol 1991; 165: 221-227.
59. Byrne J, Horgan PG, England S, Callaghan J, Given HF. A preliminary report on the usefulness of monoclonal antibodies to CA15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma. Eur J Cancer 1992; 28: 658-660.
60. Masearel I de, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow up. Br J Cancer 1992; 66: 523-527.
61. Hainsworth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA, Rennie GC, McKenzie IFC, Bennett RC. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993; 80: 459-463.
62. Elson CE, Kufe D, Johnston WW. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases. Analyst Quant Cytol Histol 1993; 15: 171-178.